Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Regular marijuana use may increase the risk of overactive bladder

Regular users of marijuana were at a greater risk of developing and suffering from severe overactive bladder disorder.

27 Sep 2022

Humanized zebrafish could aid in the search for MS drugs

The zebrafish should be known to many aquarium enthusiasts mainly because of its striking pigmentation. However, the characteristic black-blue stripes, to which the animal owes its name, only form over time.

20 Sep 2022

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Early intervention with rituximab, a drug used in the treatment of rheumatoid arthritis (RA), can reduce the risk of deterioration in myasthenia gravis, an autoimmune disease that causes loss of muscle control.

19 Sep 2022

Aerobic exercise training shows potential to restore function in individuals with thalamic atrophy

Thalamic atrophy needs to be considered in clinical studies of the functional abilities of individuals with multiple sclerosis, according to findings reported by a team of experts.

16 Sep 2022

Higher levels of microbiota engraftment linked to greater chances of transplantation success

From incurable intestinal infections to metabolic syndrome, from melanoma, to chronic inflammatory bowel disease, such as irritable bowel syndrome, to Tourette's syndrome: many diseases can potentially be cured by Fecal Microbiota Transplantation (FMT), and researchers from the Catholic University, Rome and the University of Trento have shown that the greater the level of engraftment of the transplanted microorganisms, the greater the chances of success of the therapy.

15 Sep 2022

Gut microbiome associated with multiple sclerosis risk and disease development

An international research consortium led by UC San Francisco scientists has shown significant differences between the gut bacteria profiles of multiple sclerosis (MS) patients and healthy individuals, as well as between MS patients receiving different drug treatments.

15 Sep 2022

Retired MMA fighters and boxers may see some improvement in thinking and memory scores

Boxers and mixed martial arts (MMA) fighters may see some recovery in their thinking and memory skills as well as brain structure after they stop fighting, according to a new study published in the September 14, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Sep 2022

Seven healthy lifestyle habits linked to lower risk of dementia in people with diabetes

A combination of seven healthy lifestyle habits including sleeping seven to nine hours daily, exercising regularly and having frequent social contact was associated with a lower risk of dementia in people with type 2 diabetes, according to a study published in the September 14, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Sep 2022

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated with cancer and other chronic illnesses.

13 Sep 2022

Kessler Foundation receives grant to continue the long-running "MS Fellowship in Neuropsychological Rehabilitation" program

John DeLuca, PhD, senior vice president of research and training at Kessler Foundation, received a five-year, $468,019 grant from the National Multiple Sclerosis Society to continue the long-running "MS Fellowship in Neuropsychological Rehabilitation" program.

9 Sep 2022

Annual flu shot may be linked with lower risk of stroke

Getting an annual flu shot may be associated with a lower risk of stroke, according to a study published in the September 7, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 Sep 2022

Discovery sheds light on an important aspect of gut health and mucosal immunity

Immune cells called group 3 innate lymphoid cells (ILC3s) play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.

7 Sep 2022

Recent developments in the use of nanoparticles to deliver drugs to the brain via intranasal administration

Scientists have recently reviewed research articles related to the application of inorganic nanoparticles in delivering drugs to the brain through the intranasal route.

7 Sep 2022

Researchers present their viewpoint on the link between EBV infections and the development of MS based on a previous study

Researchers presented their viewpoint on the link between Epstein-Barr virus infections and the development of multiple sclerosis based on a previous study conducted by Bjornevik et al. published in Science.

6 Sep 2022

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

As cannabidiol (CBD) use rises, high quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022 Together with CardioAcademic.

5 Sep 2022

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Regular marijuana use may increase the risk of overactive bladder

Humanized zebrafish could aid in the search for MS drugs

Rheumatoid arthritis drug can reduce the risk of deterioration in myasthenia gravis

Aerobic exercise training shows potential to restore function in individuals with thalamic atrophy

Higher levels of microbiota engraftment linked to greater chances of transplantation success

Gut microbiome associated with multiple sclerosis risk and disease development

Retired MMA fighters and boxers may see some improvement in thinking and memory scores

Seven healthy lifestyle habits linked to lower risk of dementia in people with diabetes

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

Kessler Foundation receives grant to continue the long-running "MS Fellowship in Neuropsychological Rehabilitation" program

Annual flu shot may be linked with lower risk of stroke

Discovery sheds light on an important aspect of gut health and mucosal immunity

Recent developments in the use of nanoparticles to deliver drugs to the brain via intranasal administration

Researchers present their viewpoint on the link between EBV infections and the development of MS based on a previous study

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

Understanding how microglia change their states to adapt to different areas of the brain

Gene variants associated with blood type may contribute to risk of early stroke

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Study identifies novel neutrophil biomarkers of delayed recovery in COVID-19

COVID-19 vaccine not linked to increased risk of stroke

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in